Medical Pharmacology: Diabetes Management Practice Questions
Click on the correct answer.
After, for example metformin monotherapy, is no longer sufficient:
Insulin should be added to metformin using average blood glucose as the endpoint to judge adequate glycemic control.
Sequential, stepwise, addition of drugs to metformin using maintenance of A1c levels as the target.
Both
Neither
If
metformin is no longer adequate by itself to maintain AIc desired levels:
Initial use of combination therapy to attain rapid glycemic levels is reasonable.
For the longer term combination treatment might aim for glycemic control exhibiting longer durability.
Both
Neither
Vildagliptin in combination with metformin may be better in early type II diabetes treatment compared to sequential medication addition for extending primary and secondary failure.
True
False
Vildagliptin (Galvus) is classified as a dipeptidyl peptidase 4 (DPP-4) inhibitor.
True
False
Characteristics of medications added to metformin, when metformin is no longer adequately effective as monotherapy, should take into account patient clinical characteristic/characteristics including:
Chronic kidney disease
Atherosclerotic cardiovascular disease
Heart failure
A & B
B & C
A & C
A, B & C
For patients with arteriosclerotic cardiovascular disease which one/ones of the following medications may be particularly appropriate?
Dapagliflozin
Canagliflozin
Both
Neither
For patients with arteriosclerotic cardiovascular disease which one/ones of the following medications may be particularly appropriate?
Exenatide
Liraglutide
Both
Neither
Should it be necessary to add another drug to metformin to achieve AIC targets, available options include which one/ones of the following?
Sulfonylurea
Thiozolidinediones
GLP-1 RAs
None of the above
All options, A, B, C.
Which one of the following agents which may be used to lower blood glucose levels is classified as a bile acid sequestrant?
